Lidamantle Hc Topical Cream 3-0.5pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

LidaMantle HC: Topical cream (3-0.5%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

HYDROCORTISONE; LIDOCAINE (hye droe KOR ti sone; LYE doe kane) is a corticosteroid combined with an anesthetic pain reliever. It is used to decrease swelling, itching, and pain that is caused by minor skin irritations or hemorrhoids.

In-Depth Information

LidaMantle HC 3%-0.5% Topical Cream

NDC: 103370710
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




Labeled but not FDA approved for the following conditions:
Anal Fissures, Hemorrhoids

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from freezing
LidaMantle HC 3%-0.5% Topical Cream

Reported Side Effects for LidaMantle HC 3%-0.5% Topical Cream

Striae Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Growth Inhibition Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hypothalamic-pituitary-adrenal (HPA) Suppression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Steroid Hormones Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cushing's Syndrome Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
High Pressure In Brain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
High Methemoglobin Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Thinning Of Skin Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Drug-Induced Acne Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Unusual Skin Lightening Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Hair Follicles Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Ambras Syndrome Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Sweat Rash Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Allergic Skin Reaction Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with LidaMantle HC

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5